Showing 521 - 532 results of 532 for search '"health economics"', query time: 0.07s Refine Results
  1. 521

    Multiple Sclerosis Nursing to Improve Care and Education (MSNICE): an observational study by Liesbeth Van Hijfte, Melissa Cambron, Roel Crols, Gino De La Meilleure, Nelly Govers, Ludo Vanopdenbosch, Guy Laureys, Barbara Willekens, for the MSNICE Study Group

    Published 2025-01-01
    “…Secondary outcome measures included: hospital anxiety and depression scale, coping measures, health-economic and disease-knowledge parameters. Results Three hundred thirty-four pwMS were included, of which 196 had access to an MS-nurse. …”
    Get full text
    Article
  2. 522

    The Acute VertEbRal AugmentaTion (AVERT) study: protocol for a randomised controlled, feasibility trial of spinal medial branch nerve block in hospitalised older patients with vert... by Avril Drummond, Opinder Sahota, Simon Bishop, Dritan Pasku, Apostolos Fakis, Anastasios Bastounis, Chia Wei Tan, Maribel Cameron, Yuriy Arlachov, Michal Czernicki

    Published 2022-06-01
    “…Embedded within the trial will be a health economic evaluation to understand resource utilisation and implications of the intervention and a qualitative study of the experiences and insights of trial participants and clinicians. …”
    Get full text
    Article
  3. 523
  4. 524

    Effectiveness and cost-effectiveness of a web-based routine assessment with integrated recommendations for action for depression and anxiety (RehaCAT+): protocol for a cluster rand... by Reinhold Kilian, Harald Baumeister, Yannik Terhorst, Johannes Knauer, Paula Philippi, Selina Kallinger, Sandro Eiler, Tamara Waldmann, Morten Moshagen, Martina Bader

    Published 2022-06-01
    “…Secondary outcomes are depression at discharge (T1) and 6 months follow-up (T2) as well as anxiety, satisfaction with participation in social roles and activities, pain impairment, fatigue, sleep, health-related quality of life, self-efficacy, physical functioning, alcohol, personality and health economic-specific general quality of life and socioeconomic cost and benefits at T1-3. …”
    Get full text
    Article
  5. 525
  6. 526
  7. 527

    Application of complexity theory in health and social care research: a scoping review by Áine Carroll, Claire Collins, Andrew Darley, Diarmuid Stokes, Jane McKenzie

    Published 2023-03-01
    “…Cochrane Database of Systematic Reviews, MEDLINE, CINAHL, EMBASE, Web of Science, PSYCHINFO, the NHS Economic Evaluation Database, and the Health Economic Evaluations Database were searched. In addition, a manual search of the reference lists of relevant articles was conducted. …”
    Get full text
    Article
  8. 528

    Inpatient dialectical behavior therapy combined with trauma-focused therapy for PTSD and borderline personality disorder symptoms: study design of the naturalistic trauma therapy s... by Annemieke C. Kamstra, Annemieke C. Kamstra, Sybolt O. de Vries, Maarten F. Brilman, Petty Vasilev, Manna A. Alma, Antoinette D. I. van Asselt, Antoinette D. I. van Asselt, Mia De Wolf, Robert A. Schoevers, Frederike Jörg

    Published 2025-02-01
    “…Secondary outcomes are social functioning, quality of life, borderline and cluster C personality disorder symptoms as treatment predictors, treatment trajectories, clients’ experiences and health economic consequences.MethodsThe naturalistic, longitudinal Trauma Therapy Study is conducted from January 2019 until May 2025 in a mental healthcare center in the Netherlands. …”
    Get full text
    Article
  9. 529

    Digital Health Technology Interventions for Improving Medication Safety: Systematic Review of Economic Evaluations by Widya Norma Insani, Neily Zakiyah, Irma Melyani Puspitasari, Muhammad Yorga Permana, Kankan Parmikanti, Endang Rusyaman, Auliya Abdurrohim Suwantika

    Published 2025-02-01
    “…The quality of reporting for the included studies was assessed using the CHEERS (Consolidated Health Economic Evaluation Reporting Standards) guidelines. …”
    Get full text
    Article
  10. 530

    Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer by Furnback W, Wu E, Koh CYC, Nino de Rivera Guzman JF, Kruhl C, Kotecha R, Wang BC

    Published 2025-02-01
    “…This study evaluates the cost-effectiveness of TTFields therapy concomitant with immune checkpoint inhibitors (ICIs) or docetaxel.Methods: A model-based health economic evaluation estimated lifetime costs, clinical benefits, and humanistic outcomes of TTFields therapy plus ICI or docetaxel versus ICI or docetaxel alone in metastatic NSCLC. …”
    Get full text
    Article
  11. 531
  12. 532

    Is it Time to Recognize Political Anxiety as a Social Determinant of Health? by Brandon Ambrosino

    Published 2024-12-01
    “…“Elections have Consequences: Partisan Politics may be Literally Killing Us.” Applied Health Economic Health Policy. Jan 2021: 19(1): 45-56.…”
    Get full text
    Article